In this issue:
Week 6 FC to predict long-term endoscopic healing in CD
Standardising IUS scoring in clinical trials for luminal CD
FC changes among pregnant women ±IBD, and their babies
Maternal thiopurine metabolism during pregnancy in IBD
Thiopurines and risk of AML/MDS in IBD
STRIDE-II: determining therapeutic goals for treat-to-target strategies in IBD
Outcomes after foetal exposure to biologics and thiopurines for IBD
Concomitant immunomodulator with non-anti-TNF biologics in IBD
Dietary therapies induce rapid response and remission in paediatric CD
Thiopurine monotherapy is effective in UC, less so in CD
Please login below to download this issue (PDF)